Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC

Condition:   Metastatic Castration-Resistant Prostate Cancer Interventions:   Drug: CORT125281;   Drug: Enzalutamide (Xtandi) Sponsor:   Corcept Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials